Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01819883 · ClinicalTrials.gov registry record
Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 40
- Enrollment target
NCT01819883: Completed study, sponsored by Massachusetts General Hospital.
NCT01819883 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01819883 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study investigates fat distribution in people with acromegaly. The investigator is also investigating the change of fat distribution before and after treatment of acromegaly. The investigator will compare the results of people with acromegaly to the results of healthy volunteers.
Primary Outcome
Change in intrahepatic fat after biochemical control of acromegaly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-03-30 |
What the finished NCT01819883 record still lists
NCT01819883 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01819883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01819883 about?
NCT01819883 is a clinical study titled "Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly". This study investigates fat distribution in people with acromegaly. The investigator is also investigating the change of fat distribution before and after treatment of acromegaly. The investigator will compare the results of people with acromegaly to the results of healthy volunteers.
What is the current status of trial NCT01819883?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2013-04. Estimated completion is 2016-03-30.
Who is sponsoring clinical trial NCT01819883?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia